MJFF is very interested in seeing if we can "validate" subtypes...such information would certainly be useful in the clinic (better inform families about expected course of disease, provide treatment guidance to physicians) but could also prove to be extremely informative for clinic trials (design and recruitment exclusion/inclusion criteria)...you can look at the projects we funded last summer via the press release below and/or our searchable grants database at michaeljox.org.

http://www.michaeljfox.org/newsEvent...cle.cfm?ID=197

Debi